NCT02459795View on ClinicalTrials.gov

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

PHASE3CompletedINTERVENTIONAL
Enrollment

469

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol Mebutate (Perrigo)

DRUG

Ingenol Mebutate (Reference)

DRUG

Placebo gel

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT02459795 - To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis | Biotech Hunter | Biotech Hunter